Abstract
Multimodal neuroimaging features might enable accurate classification and provide personalized treatment options in psychiatric domain. We conducted a retrospective study to investigate whether structural and functional features for predicting response to overall treatment of schizophrenia at the end of the first or a single hospitalization and in addition cross validate the results. This structural and functional magnetic resonance imaging (MRI) study included 85 and 63 patients with schizophrenia at baseline in dataset 1 and 2, respectively. After treatment, patients were classified as responders and non-responders. Features of gray matter and functional connectivity were extracted. Radiomics analysis was used to explore the predictive performance. Prediction models were based on structural features, functional features, and combined features. We found that the prediction accuracy was 80.38% (sensitivity: 87.28%; specificity 82.47%) for the model using functional features, and 69.68% (sensitivity: 83.96%; specificity: 72.41%) for the model using structural features. Our model combined both structural and functional features accurately predicted 92.04% responder and 80.23% non-responders to overall treatment, with an accuracy of 85.03%. These results highlight the power of structural and functional MRI-derived radiomics features to predict early response to treatment in schizophrenia. Prediction models of the very early treatment response in schizophrenia could augment effective therapeutic strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
L.-B.C. was supported by the National Natural Science Foundation of China (81801675) and the Fourth Military Medical University (2019CYJH). H.Y. was supported by the National Natural Science Foundation of China (81571651) and the Key Research and Development Program of Shaanxi Province (2017ZDXM-SF-048). H-N.W. was supported by the National Key R&D Program of China (2016YFC1307100) and the National Natural Science Foundation of China (81571309). W.Q. was supported by the National Natural Science Foundation of China (81471811, 81471738), the National Basic Research Program of China (2014CB543203, 2015CB856403) and the Engineering Research Center of Artificial Intelligence of Xi’an (201809170).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated for this study are available on request to the corresponding author.
